Earlier diagnosis of peripheral neuropathy in primary care: A call to action

J Peripher Nerv Syst. 2024 Mar;29(1):28-37. doi: 10.1111/jns.12613. Epub 2024 Jan 24.

Abstract

Peripheral neuropathy (PN) often remains undiagnosed (~80%). Earlier diagnosis of PN may reduce morbidity and enable earlier risk factor reduction to limit disease progression. Diabetic peripheral neuropathy (DPN) is the most common PN and the 10 g monofilament is endorsed as an inexpensive and easily performed test for DPN. However, it only detects patients with advanced neuropathy at high risk of foot ulceration. There are many validated questionnaires to diagnose PN, but they can be time-consuming and have complex scoring systems. Primary care physicians (PCPs) have busy clinics and lack access to a readily available screening method to diagnose PN. They would prefer a short, simple, and accurate tool to screen for PN. Involving the patient in the screening process would not only reduce the time a physician requires to make a diagnosis but would also empower the patient. Following an expert meeting of diabetologists and neurologists from the Middle East, South East Asia and Latin America, a consensus was formulated to help improve the diagnosis of PN in primary care using a simple tool for patients to screen themselves for PN followed by a consultation with the physician to confirm the diagnosis.

Keywords: early-diagnosis; peripheral neuropathy; primary care.

Publication types

  • Review

MeSH terms

  • Diabetic Neuropathies* / diagnosis
  • Humans
  • Primary Health Care
  • Risk Factors

Grants and funding